Insight Genetics Announces Promotions for Two Team Members
News Aug 21, 2014
Insight Genetics researches, develops and commercializes diagnostic tests that guide physicians in their diagnoses, treatment selections, and resistance monitoring for specific populations of cancer patients. Insight Genetics has recently expanded its R&D team to include 6 new members.
“Kasey and Tyler have been great additions to the Insight Genetics team,” said Christopher Callaghan, President and COO of Insight Genetics. “They have played integral roles in our laboratory operations and contributed significantly to our development of companion diagnostics in cancer. We are pleased to recognize their work and promote them to new roles within our company.”
As Research Scientist, Tyler Nielsen will coordinate projects and manage resources in Insight Genetics’ research laboratory for the development of companion diagnostics. Nielsen brings extensive knowledge and skills in molecular diagnostic procedures, concepts and practices to his scientific team. Prior to this new role, Nielsen was a Research Associate III. He received his M.A. in biomedical science from Des Moines University.
Kasey Lawrence, Senior Technology Specialist, is responsible for organizing and overseeing day-to-day operations of Insight Genetics’ Next Generation Sequencing program. Previously, Lawrence was a Research Associate III. He holds a bachelor of science in biology from Tennessee Tech University.
Scientists have identified sodium glucose transporter 2 (SGLT2) as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.READ MORE